Clinical Trials
Braintumor Website

There are 7 trials:
Facility: National Cancer Institute
NCT Trial Name# of Centers

NCT02213263

  A Study Of PF-05280586 (Rituximab-Pfizer) Or MabThera┬« (Rituximab-EU) For The First-Line Treatment Of Patients With CD20-Positive, Low Tumor Burden, Follicular Lymphoma (REFLECTIONS B328-06)
250

NCT02048059

  ANG1005 in Breast Cancer Patients With Recurrent Brain Metastases
17

NCT01158651

  Study of RAD001 (Everolimus) for Children With NF1 and Chemotherapy-Refractory Radiographic Progressive Low Grade Gliomas
12

NCT02717455

  Trial of Panobinostat in Children With Diffuse Intrinsic Pontine Glioma
10

NCT02008877

  Ganetespib and Sirolimos in Patients With MPNST (Malignant Peripheral Nerve Sheath Tumors)
7

NCT01675765

  Safety and Efficacy of Listeria in Combination With Chemotherapy as Front-line Treatment for Malignant Pleural Mesothelioma
5

NCT01518413

  Dose Escalation Study of Sorafenib and Irinotecan Combination Therapy in Pediatric Patients With Solid Tumors
4



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2017 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites